Navigation Links
Depomed Reports Third Quarter 2013 Financial Results
Date:11/5/2013

relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About DepomedDepomed, Inc. is a specialty pharmaceutical company with four approved and marketed products. Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia (PHN).  Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mild to moderate acute pain in adults.
Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain.  Glumetza® (metformin hydrochloride extended release tablets) is approved for use in adults with type 2 diabetes and is commercialized by Santarus, Inc. in the United States. Gralise and Glumetza and other product candidates are formulated with Depomed's proven, proprietary Acuform® drug delivery technology, which is designed to improve existing oral medications, allowing for extended release of medications to the upper gastrointestinal tract when dosed with food. Additional information about Depomed may be found on its website, www.depomed.com.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995. The statements that are not historical facts contained in this release are forward-looking statements that involve risks and uncertainties including, but not limited to, those related to the commercialization of Gralise, Zipsor and Lazanda and other risks detailed in the company's Securities and
'/>"/>

SOURCE Depomed, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Depomed To Report Third Quarter Fiscal Year 2013 Financial Results On Tuesday, November 5, 2013
2. Depomed Sells Type 2 Diabetes Royalties And Milestones To PDL BioPharma For $240.5 Million
3. PDL BioPharma Acquires Portfolio of Diabetes Royalty Rights and Milestones from Depomed
4. Depomed Expands Geographic Scope of License Agreement with Merck for Extended Release Metformin Patents
5. Depomed Reports Second Quarter 2013 Financial Results
6. Depomed To Report Second Quarter Fiscal Year 2013 Financial Results On Wednesday, August 7, 2013
7. FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt
8. Depomed Announces Appointment of Louis J. Lavigne, Jr. to Board of Directors
9. Depomed to Present at Wells Fargo Securities 2013 Healthcare Conference
10. Depomed To Present At Jefferies 2013 Global Healthcare Conference
11. Depomed Reports First Quarter 2013 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/23/2015)... 2015 Tianyin Pharmaceutical Inc. (NYSE Amex: ... development and sale of patented biopharmaceutical medicine, modernized traditional ... (API) today announced the business and development progress at ... 1. Following the September 2014 JCM application (No. 51268) ...
(Date:1/22/2015)... 2015  BiOptix is pleased to announce the appointment of ... Chemistry and Biochemistry. Scott joins the company after previous scientific ... throughout the course of his nearly 20 year career ... a nationally recognized thought leader in the biosensor field ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2TPI's JCM Updates on Import Registration for International Clients 2TPI's JCM Updates on Import Registration for International Clients 3TPI's JCM Updates on Import Registration for International Clients 4BiOptix Expands Leadership Team with the Appointment of Dr. Scott Klakamp as Vice President of Chemistry and Biochemistry 2
... -- China Medical Technologies, Inc. (the "Company") (Nasdaq: ... ("IVD") company, today announced that it has received approvals ... 2-alpha ("TOP2A") FISH detection kit from the State Food ... of China. The Company has received ...
... YASOO Health Inc, Morrisville, NC has introduced IronUp, ... levels of dietary iron for infants and children who ... www.yasooproducts.com/ironup ). (Photo: http://photos.prnewswire.com/prnh/20110810/CL49882 ) ... liquid iron supplement from a bioavailable source of iron ...
Cached Medicine Technology:China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit 2China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit 3YASOO Health Introduces IronUp™ 2
(Date:1/22/2015)... 2015 Blue Cross and Blue Shield of ... what it means to “Live Fearless.” , The ... share their stories about how they or someone they know ... by living in the moment. By telling these types of ...
(Date:1/22/2015)... 2015 Thousand of GranuFlo lawsuits ( ... its GranuFlo and NaturaLyte dialysis concentrates continue to move ... District Court, District of Massachusetts, Bernstein Liebhard LLP reports. ... has remanded a case filed by the state of ...
(Date:1/22/2015)... January 22, 2015 A study ... Medicine flagship journal Medicine & Science in Sports ... exercise may help reduce gastrointestinal (GI) problems associated ... , Participants in the double-blind, placebo-controlled study took ...
(Date:1/22/2015)... DC (PRWEB) January 22, 2015 Payday ... in vulnerable communities and cause financial distress to the ... by analysts at Howard University’s Center on Race and ... dollars in economic activity, payday loans at the same ...
(Date:1/22/2015)... released a new blog post explaining the importance of keeping a ... of an auto insurance policy . , Clients who driver ... their vehicle insurance policies. The safety a vehicle offers from its ... of this, drivers should always carry a first aid kit in ...
Breaking Medicine News(10 mins):Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 2Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 3Health News:Court Overseeing Federal GranuFlo Lawsuits Remands Louisiana Claim Back to State Court, Bernstein Liebhard LLP Reports 4Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Driving Safe And Other Factors That Make Auto Insurance Affordable! 2
... Dec. 7 (HealthDay News) -- Positive family attitudes and ... reduce their risk of depression, substance abuse and suicidal ... finds. The study authors also found that those ... of self-esteem and social support when they,re young adults. ...
... a way to isolate neural stem cells cells that ... from human brain tissue with unprecedented precision, an important ... system, like Parkinson,s and Huntington,s diseases and spinal cord injury. ... the University of Rochester Medical Center was published in the ...
... public health concerns about increasing antiviral resistance among certain ... of alternative antiviral treatment options. The findings are published ... of Infectious Diseases . (Please see below for links ... with two classes of drugs: M2 blockers (adamantanes) and ...
... Randy Dotinga HealthDay Reporter , MONDAY, Dec. 6 (HealthDay ... an end to sex, according to an Australian study. The ... sexually active at least once a year -- including about 1 ... older men who are sexually active say they,d love to be ...
... of making, distributing and administering millions of seasonal ... design a vaccine that confers decades-long protection from ... influenza vaccine is feasible but licensing it may ... ways to evaluate the efficacy of vaccine candidates ...
... MONDAY, Dec. 6 (HealthDay News) -- A new study finds ... risk for high blood pressure, which is a major risk ... disease and stroke in the United States decreased 65 percent ... are still higher in the southeastern United States, in blacks ...
Cached Medicine News:Health News:Parents' Acceptance May Help Protect Gay Teens 2Health News:Stem cell advance a step forward for treatment of brain diseases 2Health News:Stem cell advance a step forward for treatment of brain diseases 3Health News:Influenza virus strains show increasing drug resistance and ability to spread 2Health News:Influenza virus strains show increasing drug resistance and ability to spread 3Health News:Many Men Over 75 Still Sexually Active: Study 2Health News:Many Men Over 75 Still Sexually Active: Study 3Health News:A flu vaccine that lasts 2Health News:Race, Gender Play Part in Hypertension Risk 2
Dilator...
Microscopic scissors, curved...
Microscopic needle holder, curved...
... Back discomfort is a complaint ... wear our most comfortable apron. ... weight off the shoulders and ... shoulder pads are standard for ...
Medicine Products: